• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕28至34周重度子痫前期患者的积极或期待治疗:一项随机对照试验

Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial.

作者信息

Odendaal H J, Pattinson R C, Bam R, Grove D, Kotze T J

机构信息

Department of Obstetrics and Gynecology, University of Stellenbosch, Tygerberg, South Africa.

出版信息

Obstet Gynecol. 1990 Dec;76(6):1070-5.

PMID:2234715
Abstract

Fifty-eight women with severe preeclampsia between 28-34 weeks' gestation qualified for a randomized controlled trial to establish whether elective delivery 48 hours after administration of betamethasone (aggressive-management group) or delivery later as indicated by maternal or fetal condition (expectant-management group) was more beneficial to maternal and fetal outcome. Twenty women who qualified were not randomized because they developed maternal or fetal indications necessitating delivery within 48 hours; these newborns developed most of the complications. Expectant management was not associated with an increase in maternal complications, but it significantly prolonged the gestational age (mean 7.1 days; P less than .05), reduced the number of neonates requiring ventilation (P less than .05), and reduced the number of neonatal complications (P less than .05).

摘要

58名孕28 - 34周的重度子痫前期女性符合一项随机对照试验的条件,该试验旨在确定在给予倍他米松后48小时进行择期分娩(积极管理组)还是根据母体或胎儿状况适时延迟分娩(期待管理组)对母婴结局更有益。20名符合条件的女性未被随机分组,因为她们出现了母体或胎儿指征,需要在48小时内分娩;这些新生儿出现了大多数并发症。期待管理与母体并发症增加无关,但显著延长了孕周(平均7.1天;P<0.05),减少了需要通气的新生儿数量(P<0.05),并减少了新生儿并发症的数量(P<0.05)。

相似文献

1
Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial.孕28至34周重度子痫前期患者的积极或期待治疗:一项随机对照试验
Obstet Gynecol. 1990 Dec;76(6):1070-5.
2
[Conservative management in severe pre-eclampsia].[重度子痫前期的保守治疗]
Ginecol Obstet Mex. 2000 Feb;68:51-4.
3
Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?重度早发型子痫前期的期待治疗:胎儿生长受限是否为立即分娩的指征?
Am J Obstet Gynecol. 2000 Oct;183(4):853-8. doi: 10.1067/mob.2000.109049.
4
Expectant management of severe preeclampsia presenting before 25 weeks of gestation.妊娠25周前出现的重度子痫前期的期待治疗。
Med Sci Monit. 2007 Nov;13(11):CR523-527.
5
Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation.239例孕24至33周重度子痫前期孕妇期待治疗期间的母儿结局。
Am J Obstet Gynecol. 2004 Jun;190(6):1590-5; discussion 1595-7. doi: 10.1016/j.ajog.2004.03.050.
6
Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications.重度子痫前期晚期期待治疗:患者选择、治疗及分娩指征
Am J Obstet Gynecol. 2007 Jun;196(6):514.e1-9. doi: 10.1016/j.ajog.2007.02.021.
7
Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.妊娠28至32周时重度子痫前期的积极治疗与期待治疗:一项随机对照试验
Am J Obstet Gynecol. 1994 Sep;171(3):818-22. doi: 10.1016/0002-9378(94)90104-x.
8
The management of severe toxemia in patients at less than 36 weeks' gestation.孕周小于36周的重度子痫前期患者的管理。
Obstet Gynecol. 1979 Nov;54(5):602-5.
9
Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial.期待治疗远离足月的重度子痫前期:MEXPRE 拉丁研究,一项随机、多中心临床试验。
Am J Obstet Gynecol. 2013 Nov;209(5):425.e1-8. doi: 10.1016/j.ajog.2013.08.016. Epub 2013 Aug 14.
10
Perinatal outcomes in severe preeclamptic women between 24-33(+6) weeks' gestation.孕24至33(+6)周重度子痫前期女性的围产期结局
J Med Assoc Thai. 2008 Jan;91(1):25-30.

引用本文的文献

1
Predictive modeling of complications arising from early-onset preeclampsia in pregnant women.早发型子痫前期孕妇并发症的预测模型
Womens Health (Lond). 2025 Jan-Dec;21:17455057251348978. doi: 10.1177/17455057251348978. Epub 2025 Jul 21.
2
Nonsevere hypertensive disorders of pregnancy and oral antihypertensive medications: an argument in favor of use.非重度妊娠高血压疾病与口服抗高血压药物:支持使用的观点
Am J Obstet Gynecol MFM. 2025 Mar;7(1S):101561. doi: 10.1016/j.ajogmf.2024.101561. Epub 2024 Nov 26.
3
Assessing Severity and Need for Delivery in Early Onset Preeclampsia Before 32 Weeks of Gestation: a Delphi Consensus Procedure.
评估孕32周前早发型子痫前期的严重程度及分娩需求:德尔菲共识程序
Geburtshilfe Frauenheilkd. 2024 Aug 6;84(8):760-772. doi: 10.1055/a-2361-0563. eCollection 2024 Aug.
4
Administration of Antenatal Corticosteroids: Optimal Timing.产前皮质类固醇的给药:最佳时机
Geburtshilfe Frauenheilkd. 2024 Jan 3;84(1):48-58. doi: 10.1055/a-2202-5363. eCollection 2024 Jan.
5
Pregnancy Outcomes of Conservative Management in Preeclampsia with Severe Features.重度子痫前期保守治疗的妊娠结局
J Clin Med. 2023 Oct 4;12(19):6360. doi: 10.3390/jcm12196360.
6
Association of Maternal Medical Comorbidities with Duration of Expectant Management in Patients with Severe Preeclampsia.重度子痫前期患者母体合并症与期待治疗持续时间的相关性
Am J Perinatol. 2024 May;41(S 01):e1521-e1530. doi: 10.1055/s-0043-1768232. Epub 2023 Apr 18.
7
Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management.可溶性胎儿纤维连接蛋白-1与胎盘生长因子比值在子痫前期恰当管理中的应用价值
Healthcare (Basel). 2023 Jan 29;11(3):381. doi: 10.3390/healthcare11030381.
8
Prediction of Delivery Within 7 Days After Diagnosis of Early Onset Preeclampsia Using Machine-Learning Models.使用机器学习模型预测早发型子痫前期诊断后7天内分娩情况
Front Cardiovasc Med. 2022 Jul 1;9:910701. doi: 10.3389/fcvm.2022.910701. eCollection 2022.
9
Expectant Versus Interventionist Care in the Management of Severe Preeclampsia Remote from Term: A Systematic Review.期待治疗与干预治疗在管理严重子痫前期中的应用:一项系统综述。
Rev Bras Ginecol Obstet. 2021 Aug;43(8):627-637. doi: 10.1055/s-0041-1733999. Epub 2021 Sep 21.
10
PROVE-Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia.PROVE-子痫前期产科不良事件:子痫前期生物库和数据库的建立。
Cells. 2021 Apr 20;10(4):959. doi: 10.3390/cells10040959.